Cytokines in the rheumatic diseases (Q35733792)

10 August 2017

1 reference

title

Cytokines in the rheumatic diseases (English)

1 reference

10 August 2017

2

Cem Gabay

1 reference

10 August 2017

William P Arend

1

1 reference

PubMed ID

15061568

10 August 2017

language of work or name

1 reference

1 February 2004

1 reference

Rheumatic Diseases Clinics of North America

10 August 2017

1 reference

10 August 2017

30

1 reference

10 August 2017

1

1 reference

10 August 2017

41-67, v-vi

1 reference

The autoimmune pathogenesis of rheumatoid arthritis: role of autoreactive T cells and new immunotherapies

10 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Rheumatoid arthritis--a molecular understanding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Role of cytokines in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Physiology of cytokine pathways in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Cytokine pathways and joint inflammation in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Cytokines in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

The innate immune system in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Presentation of self peptides by dendritic cells: possible implications for the pathogenesis of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Could endogenous self-peptides presented by dendritic cells initiate rheumatoid arthritis?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

IL-12 in autoimmunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

The role of IL-12 in inflammatory activity of patients with rheumatoid arthritis (RA).

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Local interleukin-12 gene transfer promotes conversion of an acute arthritis to a chronic destructive arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

The role of interleukin–15 in T–cell migration and activation in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Increased expression of IL-15 in the synovium of patients with rheumatoid arthritis compared with patients with Yersinia-induced arthritis and osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells In vitro and in the SCID mouse-human rheumatoid arthritis model In vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Interleukin 15: a proinflammatory role in rheumatoid arthritis synovitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Interleukin-15 up-regulates the expression of CD154 on synovial fluid T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Fibroblast-like synoviocytes from rheumatoid arthritis patients express functional IL-15 receptor complex: endogenous IL-15 in autocrine fashion enhances cell proliferation and expression of Bcl-x(L) and Bcl-2

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Interleukin-18, rheumatoid arthritis, and tissue destruction

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Interleukin-18: A novel cytokine in inflammatory rheumatic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

A proinflammatory role for IL-18 in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Interferon-gamma-inducing activity of interleukin-18 in the joint with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Expression of interleukin‐18 and its monokine‐directed function in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Chemoattraction of Human T Cells by IL-18

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Evidence of IL-18 as a novel angiogenic mediator

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Reduced Incidence and Severity of Collagen-Induced Arthritis in Mice Lacking IL-18

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

An IFN-gamma-independent proinflammatory role of IL-18 in murine streptococcal cell wall arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Interleukin 7 induces cytokine secretion and tumoricidal activity by human peripheral blood monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Interleukin 7 stimulates tumour necrosis factor alpha and Th1 cytokine production in joints of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Interleukin-7: from bench to clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Interleukin-17 enhances tumor necrosis factor alpha-induced synthesis of interleukins 1,6, and 8 in skin and synovial fibroblasts: a possible role as a "fine-tuning cytokine" in inflammation processes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages: a possible role in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Effect of interleukin 17 on proteoglycan degradation in murine knee joints

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Potential contribution of IL-17-producing Th(1)cells to defective repair activity in joint inflammation: partial correction with Th(2)-promoting conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Interleukin 17 synergises with tumour necrosis factor alpha to induce cartilage destruction in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Contribution of interleukin 17 to human cartilage degradation and synovial inflammation in osteoarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Interleukin 17 induces cartilage collagen breakdown: novel synergistic effects in combination with proinflammatory cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

High in vivo expression of interleukin-17 receptor in synovial endothelial cells and chondrocytes from arthritis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Expression, modulation and signalling of IL-17 receptor in fibroblast-like synoviocytes of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Reduction of joint inflammation and bone erosion in rat adjuvant arthritis by treatment with interleukin-17 receptor IgG1 Fc fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Role of the endothelium in chronic inflammatory synovitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Review: angiogenesis: implications for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Angiogenesis and arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Angiogenesis in inflammatory joint disease: a target for therapeutic intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Angiopoietin-1 is expressed in the synovium of patients with rheumatoid arthritis and is induced by tumour necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Synoviocyte-derived CXCL12 is displayed on endothelium and induces angiogenesis in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Angiogenesis inhibition suppresses collagen arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Adhesion molecules as targets for the treatment of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Adhesion molecules: a rheumatologic perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Chemokines--chemotactic cytokines that mediate inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Roles of IL-1 in the development of rheumatoid arthritis: consideration from mouse models

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Macrophage migration inhibitory factor: an emerging therapeutic target in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Control of fibroblast-like synoviocyte proliferation by macrophage migration inhibitory factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: interaction with glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Involvement of IL-6, apart from its role in immunity, in mediating a chronic response during experimental arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

A point mutation of Tyr-759 in interleukin 6 family cytokine receptor subunit gp130 causes autoimmune arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Update on spondyloarthropathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Cytokines and juvenile idiopathic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Cytokines in osteoarthritis: mediators or markers of joint destruction?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Cytokines and systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune re

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Tumor necrosis factor alpha/cachectin is a growth factor for thymocytes. Synergistic interactions with other cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Induction of apoptosis in mature T cells by tumour necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Tumor necrosis factor receptor p55 mediates deletion of peripheral cytotoxic T lymphocytesin vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Accelerated autoimmunity and lupus nephritis in NZB mice with an engineered heterozygous deficiency in tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Drug-induced systemic lupus erythematosus associated with etanercept therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

How TRAIL kills cancer cells, but not normal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

On the TRAIL to apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

The apoptotic ligands TRAIL, TWEAK, and Fas ligand mediate monocyte death induced by autologous lupus T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Immunobiology of tumor necrosis factor receptor superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Acute-phase proteins and other systemic responses to inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Triple check for antigen specificity of B cells during germinal centre reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Germinal centers: form and function.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

BAFF AND APRIL: a tutorial on B cell survival

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

BAFF: a fundamental survival factor for B cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Synthesis and release of B-lymphocyte stimulator from myeloid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Modulation of the immunoglobulin dysregulation in GvH- and SLE-like diseases by the murine IL-4 receptor (IL-4-R)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Development of lupus in BXSB mice is independent of IL-4

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Constitutive expression of interleukin (IL)-4 in vivo causes autoimmune-type disorders in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Interleukin-4 protects against a genetically linked lupus-like autoimmune syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Immune complexes from SLE sera induce IL10 production from normal peripheral blood mononuclear cells by an FcgammaRII dependent mechanism: implications for a possible vicious cycle maintaining B cell hyperactivity in SLE.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Renal expression of IL-6 and TNFalpha genes in lupus nephritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

p38 Mitogen-activated protein kinase contributes to autoimmune renal injury in MRL-Fas lpr mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Identification of Fibroblasts Responsible for Increased Collagen Production in Localized Scleroderma by In Situ Hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Localization of collagen mRNA in normal and scleroderma skin by in-situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Scleroderma and Smads: dysfunctional Smad family dynamics culminating in fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Decreased collagenase expression in cultured systemic sclerosis fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Identification of an IL1A gene segment that determines aberrant constitutive expression of interleukin-1 alpha in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Endogenous IL-1alpha from systemic sclerosis fibroblasts induces IL-6 and PDGF-A.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Peripheral blood T lymphocytes from systemic sclerosis patients show both Th1 and Th2 activation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Regulation of interleukin-4 on collagen gene expression by systemic sclerosis fibroblasts in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Increased interleukin-17 production in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Transforming growth factor-beta and connective tissue growth factor: key cytokines in scleroderma pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Reduction of bleomycin induced lung fibrosis by transforming growth factor beta soluble receptor in hamsters

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

New developments in the role of cytokines and chemokines in inflammatory myopathies.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Differential expression of chemokines in inflammatory myopathies.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Cytokines block the effects of insulin-like growth factor-I (IGF-I) on glucose uptake and lactate production in skeletal muscle but do not influence IGF-I-induced changes in protein turnover

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Decreased expression of interleukin-1alpha, interleukin-1beta, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Downregulation of TGF-beta1 mRNA and protein in the muscles of patients with inflammatory myopathies after treatment with high-dose intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Transforming growth factor-beta 1 in polymyositis and dermatomyositis correlates with fibrosis but not with mononuclear cell infiltrate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Increased IL-15 production of muscle cells in polymyositis and dermatomyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Increased CD40 expression on muscle cells of polymyositis and dermatomyositis: role of CD40-CD40 ligand interaction in IL-6, IL-8, IL-15, and monocyte chemoattractant protein-1 production

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Pathogenic principles in giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Disease patterns and tissue cytokine profiles in giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Functional profile of tissue-infiltrating and circulating CD68+ cells in giant cell arteritis. Evidence for two components of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Platelet-derived growth factor, intimal hyperplasia, and ischemic complications in giant cell arteritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Treatment of giant cell arteritis: interleukin-6 as a biologic marker of disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

CD28 negative T cells are enriched in granulomatous lesions of the respiratory tract in Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Peripheral blood and granuloma CD4(+)CD28(-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Elevated monocytic IL-12 and TNF-alpha production in Wegener's granulomatosis is normalized by cyclophosphamide and corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Effectiveness of TNF-alpha blockade with infliximab in refractory Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Interleukin 8 in Behçet's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Adamantiades-Behçet's disease: interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Cytokine profile in Behçet's disease patients. Relationship with disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

Behçet's disease: a new target for anti-tumour necrosis factor treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2803%2900115-7

7 January 2021

10.1016/S0889-857X(03)00115-7

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15061568